Hisashi Makino

6PUBLICATIONS
2CO-AUTHORS
Molecular targetsRespiratory diseasesMajor global burdens of diseasePredictive and prognostic markersLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 26, 2026
Effect of empagliflozin on urinary albumin excretion and hypoxic biomarkers in early diabetic kidney disease: A randomised double-blind, placebo-controlled trial.

Hisashi Makino, Masato Kasahara, Ryuzo Takashima

|Jan 11, 2023
Diabetic microvascular complications predicts non-heart failure with reduced ejection fraction in type 2 diabetes.

Mayu Tochiya, Hisashi Makino, Tamiko Tamanaha

|Sep 05, 2020
A Prospective Longitudinal Study on the Relationship Between Glucose Fluctuation and Cognitive Function in Type 2 Diabetes: PROPOSAL Study Protocol.

Masaki Matsubara, Hisashi Makino, Kazuo Washida

|Jul 31, 2019
Effect of tofogliflozin on cardiac and vascular endothelial function in patients with type 2 diabetes and heart diseases: A pilot study.

Mayu Tochiya, Hisashi Makino, Tamiko Tamanaha

|Jul 24, 2019
Addition of low-dose liraglutide to insulin therapy is useful for glycaemic control during the peri-operative period: effect of glucagon-like peptide-1 receptor agonist therapy on glycaemic control in patients undergoing cardiac surgery (GLOLIA study).

H Makino, A Tanaka, K Asakura

|May 30, 2019
Effect of linagliptin on oxidative stress markers in patients with type 2 diabetes: a pilot study.

Hisashi Makino, Miki Matsuo, Ai Hishida

Pageof 1

Frequent Collaborators

1 joint publications

Mayu Tochiya

1 joint publications

Naoki Ozu